- Czaja, A.J. (1998) "Treatment of autoimmune hepatitis", In: Krawitt, E.L., Wiesner, R.H. and Nishioka, M., eds, Autoimmune Liver Diseases, 2nd Ed. (Elsevier, Amsterdam), pp 499-515.
- Johnson, P.J. and McFarlane, I.G. (1993) "Meeting report: International Autoimmune Hepatitis Group", Hepatology 18, 998-1005.
- Alvarez, F., Berg, P.A., Bianchi, F.B., Manns, M.P., McFarlane, I.G., Meyer zum Buschenfelde, K.H., et al. (1999) "International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis", J. Hepatol. 31, 929-938.
- Homberg, J.C., Abuaf, N., Bernard, O., Islam, S., Alvarez, F., Khalil, S.H., et al. (1987) "Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis", Hepatololgy 7, 1333-1339.
- Czaja, A.J. (1999) "Behaviour and significance of autoantibodies in type 1 autoimmune hepatitis", J. Hepatol. 30, 394-401.
- Czaja, A.J. and Manns, M.P. (1995) "The validity and importance of subtypes in autoimmune hepatitis: a point of view", Am. J. Gastroenterol. 90, 1206-1211.
- Lapierre, P., Hajoui, O., Homberg, J.C. and Alvarez, F. (1999) "Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis", Gastroenterology 116, 643-649.
- Manns, M., Gerkuen, G. and Kyriatsoulis, A. (1987) "Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen", Lancet 32, 635-640.
- Stechemesser, E., Klein, R. and Berg, P.A. (1993) "Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis", Hepatology 18, 1-9.
- Wies, I., Brunner, S., Henninger, J., Herkel, J., Kanzler, S., Meyer zum Buschenfelde, K.H., et al. (2000) "Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis", Lancet 355, 1510-1515.
- Costa, M., Rodriguez-Sanchez, J.L., Czaja, A.J. and Gelpi, C. (2000) "Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis", Clin. Exp. Immunol. 121, 364-374.
- Wachter, B., Kyriatsoulis, A., Lohse, A.W., Gerken, G., Meyer zum Buschenfelde, K.H. and Manns, M. (1990) "Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies", J. Hepatol. 11, 232-239.
- Wesierska-Gadek, J., Grimm, R., Hitchman, E. and Penner, E. (1998) "Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis", Gastroenterology 114, 329-335.
- Czaja, A.J., Carpenter, H.A. and Manns, M.P. (1999) "Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis", Gastroenterology 105, 1522-1528.
- Kanzler, S., Weidemann, C., Gerken, G., Lohr, H.F., Galle, P.R., Meyer zum Buschenfelde, K.H., et al. (1999) "Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis", J. Hepatol. 31, 635-640.
- Baeres, M., Herkel, J., Czaja, A.J., Wies, I., Kanzler, S., Cancado, E.L., et al. (2002) "Establishment of standardized SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics", Gut 51, 259-264.
- Czaja, A.J., Donaldson, P.T. and Lohse, A.W. (2002) "Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis", Am. J. Gastroenterol. 97, 413-419.
- Amar-Costesec, A., Beaufay, H., Wibo, M., Thines-Sempoux, D., Feytmans, E., Robbi, M., et al. (1974) "Analytical study of microsomes and isolated subcellular membranes from rat liver. II. Preparation and composition of the microsomal fraction", J. Cell. Biol. 61, 201-212.
- Vitozzi, S., Lapierre, P., Djilali-Saiah, I. and Alvarez, F. (2002) "Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant fusion protein", J. Immunolol. Methods 262, 103-110.
- Margulies, D.H. (1995) "Molecular biology", In: Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. and Strober, W., eds, Current Protocol in Immunology (John Wiley & Sons, New York) Vol. 2, pp 101101-101111.
- Coligan, J.E. (1999) "Protein", In: Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. and Strober, W., eds, Current Protocol in Immunology (John Wiley & Sons, New York) Vol. 2, pp 831-839.
- Towbin, H., Staehelin, T. and Gordon, J. (1979) "Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheets", Proc. Natl Acad. Sci. USA 76, 4350-4354.
- Ma, Y., Okamoto, M., Thomas, M.G., Bogdanos, D.P., Lopes, A.R., Portmann, B., et al. (2002) "Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease", Hepatology 35, 658-664.
- Herkel, J., Heidrich, B., Nieraad, N.,Wies, I., Rother,M. and Lohse, A.W. (2002) "Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas", Hepatology 35, 403-408.
- Czaja, A.J., Carpenter, H.A. and Manns, M.P. (1999) "Antibodies to soluble liver antigen in autoimmune hepatitis", J. Hepatol. 31, 635-640.
- Ballot, E., Homberg, J.C. and Johanet, C. (2000) "Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis", J. Hepatol. 33, 208-215.
- Peakman, M., Lobo-Yeo, A., Mieli-Vergani, G., Davies, E.T., Mowat, A.P. and Vergani, D. (1987) "Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidences for IgG1 subclasses restriction, policlonality and non-cross reactivity with hepatocyte surfaces antigen", Clin. Exp. Immunol. 69, 543-549.
- Maran, R., Dueymes, M., Le Corre, R., Renaudineau, Y., Shoenfeld, Y. and Youinou, P. (1997) "IgG subclasses of human autoantibodies", Ann. Med. Intern. 148, 29-38.
- Muratori, L., Cataleta, M., Muratori, P., Lenzi, M. and Bianchi, F.B. (1998) "Liver kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis", Gut 42, 721-726.
Patients with Insulin-dependent Diabetes but not those with Non-insulin-dependent Diabetes have Anti-sulfatide Antibodies as Determined with a New ELISA Assay
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.